Organic compounds -- part of the class 532-570 series – Organic compounds – Amino nitrogen containing
Reexamination Certificate
2003-04-18
2009-10-06
Zucker, Paul A (Department: 1621)
Organic compounds -- part of the class 532-570 series
Organic compounds
Amino nitrogen containing
C564S088000, C564S086000, C564S085000, C564S084000, C564S080000
Reexamination Certificate
active
07598418
ABSTRACT:
A medicament for enhancing an effect of a cancer therapy based on a mode of action of DNA injury, which comprises as an active ingredient a compound represented by the following general formula (I) or a salt thereof:wherein one of R1and R2represents hydrogen atom and the other represents the formula —X-A wherein A represents hydrogen atom or an acyl group, X represents oxgen atom or NH; one of R3and R4represents hydrogen atom and the other represents the following formula:wherein Y represents a sulfonyl group or a carbonyl group, R5represents a cyclic group, Z represents a single bond or a C1to C4alkylene group, R6represents hydrogen atom or a C1to C6alkyl group.
REFERENCES:
patent: 4579805 (1986-04-01), Bergthaller et al.
patent: 5378715 (1995-01-01), Stein et al.
patent: 5399487 (1995-03-01), Butenas et al.
patent: 5707985 (1998-01-01), McKenzie et al.
patent: 6417181 (2002-07-01), Bender et al.
patent: 1402890 (2004-03-01), None
patent: 827446 (1960-02-01), None
patent: 1364952 (1974-08-01), None
patent: 2397817 (2004-08-01), None
patent: 48-30733 (1973-04-01), None
patent: 60-140240 (1985-07-01), None
patent: 3-217459 (1991-09-01), None
patent: 5-503721 (1993-06-01), None
patent: 6-504052 (1994-05-01), None
patent: 2001-504492 (2001-04-01), None
patent: 1646258 (1996-02-01), None
patent: 92/07557 (1992-05-01), None
patent: 92/12119 (1992-07-01), None
patent: 98/22125 (1998-05-01), None
patent: WO99/37609 (1999-07-01), None
patent: 03-035621 (2003-05-01), None
Marsilje H. T. et al. Bioorganic & Medicinal Chemistry Letters, 2000, vol. 10, pp. 477-481.
Stein et al. Journal of Medicinal Chemistry 1995, vol. 38, pp. 1344-1354.
Butenas et al. CAS abstract of: Biochemistry, 1992, vol. 31, pp. 5399-5411.
The Merck Manual of diagnosis and therapy, 7thedition, 1999, Published by Merch Research Laboratories, pp. 397-398, 948-949, 1916 and 1979-1981.
CAplus abstract of SU 1646258 published 1996.
P.R. Graves et al., J. of Biol. Chem., vol. 275, No. 8, Feb. 25, 2000, pp. 5600-5605.
B. Hu et al., J. Biol. Chem., vol. 276, No. 21, May 25, 2001, pp. 17693-17698.
K. Tomita et al., Jpn. J. Cancer Res., vol. 80, Jan. 1989, pp. 83-88.
A. Monks et al., Invest. New Drugs, vol. 18, 2000, pp. 95-107.
E.C. Busby et al., Cancer Res., vol. 60, Apr. 15, 2000, pp. 2108-2112.
J.N. Sarkaria et al., Cancer Res., vol. 59, Sep. 1, 1999, pp. 4375-4382.
B.-B.S. Zhou et al., J. Biol. Chem., vol. 275, No. 14, Apr. 7, 2000, pp. 10342-10348.
Z. Shi et al., Cancer Res., vol. 61, Feb. 1, 2001, pp. 1065-1072.
K. Kawakami et al., Biochem. Biophys. Res. Commun., vol. 219, 1996.
W.-Y. Wang et al., Acta Pharmacol Sin, vol. 21, No. 1, Jan. 2000, pp. 35-40.
J. Bendig et al., Tetrahedron, vol. 48, No. 42, 1992, pp. 9207-9216.
S.R. Wilson et al., Tetrahedron, vol. 49, No. 17, 1993, pp. 3655-3663.
R.D. Desai et al., Jour. Indian Chem. Soc., vol. 46, No. 5, 1969, pp. 411-415.
S. Fujita et al., Anal. Chem., vol. 66, 1994, pp. 1347-1353.
English Language Abstract of JP 3-217459, Published Sep. 25,1991.
U.S. Appl. No. 10/478,687.
U.S. Appl. No. 10/488,254.
Gebauer-Fülnegg and Glückmann,Monatshefte fuer Chemievol. 53-54: pp. 100-110 (1929).
Itai Akiko
Muto Susumu
Greenblum & Bernstein P.L.C.
Institute of Medicinal Molecular Design Inc.
Valenrod Yevegeny
Zucker Paul A
LandOfFree
Amide derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Amide derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amide derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4123302